N/A
Completed N=30
EMR Outcomes: Anxiety and Depression in Epilepsy
Source: ClinicalTrials.gov NCT03879525 ↗Enrolled (actual)
30
Serious AEs
6.7%
Results posted
Jan 2022
Primary outcomePrimary: Percentage of Participants Retained in the Study in the EMR Arm — 67 percentage of participants
Summary
The purpose of this research is to find out how people with epilepsy and possible symptoms of anxiety or depression are doing for 6 months after a regular epilepsy clinic visit. Participants in this study will complete questionnaires either by phone or via the patient portal.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants Retained in the Study in the EMR Arm |
67 | — |
| SECONDARY Percentage of Participants Retained in the Study in the Phone Arm |
100 | — |
| SECONDARY Quality of Life in Epilepsy-10 (QOLIE-10) |
57.6; 62.6 | — |
| SECONDARY Generalized Anxiety Disorder 7-item (GAD-7) Scale |
7.7; 8.5 | — |
| SECONDARY Neurological Disorders Depression Inventory (NDDI-E) |
14.7; 13.8 | — |
Eligibility Criteria
Inclusion Criteria
- Age 18 or older
- Completed electronic questionnaires independently in clinic
- Epilepsy diagnosis (clinician impression or EEG-based)
- Borderline or high anxiety or depression symptoms at baseline
- GAD-7 score > 7 (anxiety)
- NDDI-E score > 13 (depression)
Exclusion Criteria
- Passive suicidal ideation (NDDI-E item 4 score of 3 or 4)
- Age <18 years
Data sourced from ClinicalTrials.gov (NCT03879525). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.